XML 21 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Oct. 01, 2022
Current assets:    
Cash and cash equivalents $ 667,570 $ 529,857
Accounts receivable, net of allowances of approximately $8 million as of September 30, 2023 and October 1, 2022, respectively 1,230,771 1,138,894
Contract assets 445,757 475,721
Inventories 1,477,223 1,684,099
Prepaid expenses and other current assets 58,249 62,044
Total current assets 3,879,570 3,890,615
Property, plant and equipment, net 632,836 575,170
Deferred income tax assets 177,597 209,554
Other 183,965 160,192
Total assets 4,873,968 4,835,531
Current liabilities:    
Accounts payable 1,612,833 2,041,434
Accrued liabilities 267,148 281,599
Accrued payroll and related benefits 127,406 130,892
Short-term debt, including current portion of long-term debt 25,945 17,500
Total current liabilities 2,033,332 2,471,425
Long-term liabilities:    
Long-term debt 312,327 329,237
Other 209,684 215,333
Total long-term liabilities 522,011 544,570
Commitments and contingencies
Stockholders' equity:    
Preferred stock, $0.01 par value, authorized 5,000 shares, none issued and outstanding 0 0
Common stock, $0.01 par value, authorized 166,667 shares; 111,550 and 110,160 shares issued and 56,833 and 57,394 shares outstanding as of September 30, 2023 and October 1, 2022, respectively 568 574
Treasury stock, 54,718 and 52,766 shares as of September 30, 2023 and October 1, 2022, respectively, at cost (1,485,252) (1,378,159)
Additional paid-in capital 6,512,763 6,380,774
Accumulated other comprehensive income 70,879 56,325
Accumulated deficit (2,930,008) (3,239,978)
Noncontrolling interest 149,675 0
Equity, Including Portion Attributable to Noncontrolling Interest, Total 2,318,625 1,819,536
Total liabilities and stockholders' equity $ 4,873,968 $ 4,835,531